BW Communities

Articles for Startups

Government Working On Recommendations To Reduce Bulk Drug Imports

Many state governments have shown interest in setting up bulk drug manufacturing units and soon the country will have many such hubs, Pharmaceuticals Secretary V K Subburaj said

Read More
Apollo Ties Up With Google Health Card In India

Apollo has compiled comprehensive information on 400 diseases including malaria and dengue which would show up once the keyword of the disease was typed in

Read More
Cadila Gets Negative US FDA Observations For Matoda SEZ Unit

The American regulator had in January issued similar notice to the company's Moraiya manufacturing unit

Read More
Two Indian Generics Makers End Battle To Copy Drugs Amid Patent Debate

Two Indian drugmakers said they had given up a battle to copy drugs developed by Bristol Myers Squibb and AstraZeneca , blaming a lack of government support for cheap generics and pressure from Big Pharma

Read More
Investors Stick With Pfizer CEO After Allergan Deal Collapse

In 2014, Pfizer failed in its unsolicited $118 billion bid to buy London-based drugmaker AstraZeneca Plc after that deal ran into staunch opposition from British politicians

Read More
Abbott India: A Clean Bill Of Health

On his watch, Abbott India, has gone from strength to strength. Today, Abbott’s diversified operations in India have crossed $1 billion

Read More
Pfizer, Allergan Scrap $160 Billion Deal After US Tax Rule Change

US drugmaker Pfizer Inc and Ireland-based Allergan Plc walked away from their $160 billion merger on Wednesday, a major win for President Barack Obama, who has been pushing to curb deals in which companies move overseas to save on taxes

Read More
Healthcare Just A Tweet Away

On World Health Day, two disruptive platforms, Practo and Twitter partner to revolutionize healthcare access

Read More
Obama's Inversion Curbs Kill Pfizer's $160 Billion Allergan Deal

Pfizer will have to pay Allergan up to $400 million for its expenses as a result of terminating the deal, according to their merger agreement

Read More
Lupin Says It Sees No Supply Disruption At Plant Despite FDA Observations

The company said it did not expect any disruption to supply from its main manufacturing plant despite what it called minor observations made by the US Food and Drug Administration after an audit

Read More

Subscribe to our newsletter to get updates on our latest news